Investors Overview

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. We work to solve the greatest challenges in healthcare that patients and clinicians face today and in the future.

Sustainability Report

GE HealthCare’s Inaugural Sustainability Report

Latest Presentations

Show all

GE HealthCare Second Quarter 2023 Earnings Conference Call

Webcast

Presentation 1.4 MB

Press Release 1.2 MB

Earnings Supplemental Info 95.4 KB

View all events

>$1bn

annual R&D & product investment spend in 2022

1bn+

patients served annually

4m+

units installed across the globe

$18.3bn

revenue in 2022

News & events

Stay up to date with GE HealthCare's latest investor news and events

News
Latest events

September 22, 2023

GE HealthCare Announces Cash Dividend for Third Quarter of 2023

News Release

September 20, 2023

GE HealthCare Shares Key Focus Areas and Future Goals in its Inaugural Sustainability Report

News Release

September 18, 2023

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

News Release

September 12, 2023 at 1:35 PM EDT

Morgan Stanley 21st Annual Global Healthcare Conference

September 7, 2023 at 8:00 AM EDT

Wells Fargo 2023 Healthcare Conference

July 25, 2023 at 8:00 AM EDT

GE HealthCare Second Quarter 2023 Earnings Conference Call

More information is coming soon.

Future of AI and deep learning technology

Following the success of AIR Recon DL in MR, our Effortless Recon DL team has launched the next breakthrough. Sonic DL is a state-of-the-art deep learning technology designed to accelerate image acquisition in MR. In cardiac imaging, Sonic DL enables faster scans, with speeds up to 12 times faster than conventional methods, while maintaining high image quality.

Jan Makela, President & CEO, Imaging, GE HealthCare